GlassScriptPhysician profile
Alexander M Hamling
NPI 1538379326
$22,932.36
in general payments reported to CMS, 2019-2025
12 companies · $6,360 in 2025
The $6,360 reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $739 · 2020: $6,618 · 2021: $138 · 2022: $1,810 · 2023: $1,061 · 2024: $6,206 · 2025: $6,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,195 · Travel and Lodging: $3,035 · Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,195.00 |
| Travel and Lodging | $3,034.89 |
| Food and Beverage | $1,397.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $18,711.90 | 2019-2025 | Varivax, Enflonsia, Recombivax Hb |
| Sanofi Pasteur INC. | $2,782.00 | 2019-2020 | |
| Biofire Diagnostics, LLC | $500.00 | 2019 | |
| Glaxosmithkline, LLC. | $245.78 | 2019-2023 | Arexvy |
| Stryker Corporation | $170.65 | 2022 | |
| Celgene Corporation | $125.00 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $123.00 | 2024 | Dupixent |
| Genzyme Corporation | $93.75 | 2024 | |
| Corium, LLC | $51.88 | 2023 | Azstarys |
| Astrazeneca Pharmaceuticals LP | $47.61 | 2025 | |
| Seqirus USA INC | $46.39 | 2022 | |
| Cognoa, INC. | $34.40 | 2023 | Canvas Dx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Hamling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.